GKL-006Allo Injection in Patients With Advanced Solid Tumors

Clinical trial NCT07704515 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07704515
Sponsor: Beijing Gene Key Life Technology Co., Ltd
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumor Malignancies

Start date: 2026-08-30
Primary completion: 2028-09-30
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.